DE69821655D1 - Verwendung von phospholipiden zur herstellung eines arzneimittels zur vorbeugung von adhäsionen - Google Patents

Verwendung von phospholipiden zur herstellung eines arzneimittels zur vorbeugung von adhäsionen

Info

Publication number
DE69821655D1
DE69821655D1 DE69821655T DE69821655T DE69821655D1 DE 69821655 D1 DE69821655 D1 DE 69821655D1 DE 69821655 T DE69821655 T DE 69821655T DE 69821655 T DE69821655 T DE 69821655T DE 69821655 D1 DE69821655 D1 DE 69821655D1
Authority
DE
Germany
Prior art keywords
phospholipides
producing
medicinal product
preventing adhesions
medicament
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69821655T
Other languages
English (en)
Other versions
DE69821655T2 (de
Inventor
Andrew Hills
Alan Woodcock
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Britannia Pharmaceuticals Ltd
Original Assignee
Britannia Pharmaceuticals Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Britannia Pharmaceuticals Ltd filed Critical Britannia Pharmaceuticals Ltd
Publication of DE69821655D1 publication Critical patent/DE69821655D1/de
Application granted granted Critical
Publication of DE69821655T2 publication Critical patent/DE69821655T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/683—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
    • A61K31/685—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols one of the hydroxy compounds having nitrogen atoms, e.g. phosphatidylserine, lecithin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
DE69821655T 1998-04-03 1998-11-26 Verwendung von phospholipiden zur herstellung eines arzneimittels zur vorbeugung von adhäsionen Expired - Lifetime DE69821655T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB9807298 1998-04-03
GBGB9807298.6A GB9807298D0 (en) 1998-04-03 1998-04-03 Medicament
PCT/GB1998/003540 WO1999051244A1 (en) 1998-04-03 1998-11-26 Use of phospholipids for the manufacture of a medicament for the prevention of adhesions

Publications (2)

Publication Number Publication Date
DE69821655D1 true DE69821655D1 (de) 2004-03-18
DE69821655T2 DE69821655T2 (de) 2004-12-23

Family

ID=10829890

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69821655T Expired - Lifetime DE69821655T2 (de) 1998-04-03 1998-11-26 Verwendung von phospholipiden zur herstellung eines arzneimittels zur vorbeugung von adhäsionen

Country Status (12)

Country Link
US (1) US6719960B1 (de)
EP (1) EP1069902B1 (de)
JP (1) JP4287050B2 (de)
AT (1) ATE259234T1 (de)
AU (1) AU1251799A (de)
CA (1) CA2327693C (de)
DE (1) DE69821655T2 (de)
DK (1) DK1069902T3 (de)
ES (1) ES2214748T3 (de)
GB (2) GB9807298D0 (de)
PT (1) PT1069902E (de)
WO (1) WO1999051244A1 (de)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9807298D0 (en) 1998-04-03 1998-06-03 Britannia Pharmaceuticals Ltd Medicament
US6156294A (en) * 1999-11-28 2000-12-05 Scientific Development And Research, Inc. Composition and method for treatment of otitis media
GB0007150D0 (en) * 2000-03-24 2000-05-17 Lamellar Therapeutics Limited Immunotherapeutic methods and compositions
WO2002094283A2 (en) * 2001-05-21 2002-11-28 Britannia Pharmaceuticals Limited Use of phospholipids in the treatment of degenerative lung disease such as copd or cystic fibrosis and to enhance delivery of drugs
GB0115505D0 (en) * 2001-06-25 2001-08-15 Britannia Pharmaceuticals Ltd Prevention of surgical adhesions
GB0200704D0 (en) * 2002-01-14 2002-02-27 Britannia Pharmaceuticals Ltd Use of phospholipids in peritoneal dialysis
GB0207653D0 (en) 2002-04-03 2002-05-15 Lamellar Therapeutics Ltd Methods of using lamellar bodies for therapeutic purposes
EP1426053A1 (de) * 2002-12-03 2004-06-09 Fresenius Kabi Deutschland GmbH Verwendung von amphiphilen Lipiden zur Hemmung von Tumormetastasierung
GB0322448D0 (en) 2003-09-25 2003-10-29 Lamellar Therapeutics Ltd Using lamellar bodies to modify linear biological macro molecules
WO2005035035A1 (en) * 2003-10-07 2005-04-21 Northgate Technologies Inc. System and method for delivering a substance to a body cavity
EP1680173B1 (de) * 2003-10-31 2011-01-12 Trudell Medical International System zur manipulierung eines katheters für die ablage einer substanz in einer körperhöhle
GB0426010D0 (en) * 2004-11-26 2004-12-29 Britannia Pharmaceuticals Ltd Improvements in or relating to organic materials
US9119901B2 (en) 2005-04-28 2015-09-01 Warsaw Orthopedic, Inc. Surface treatments for promoting selective tissue attachment to medical impants
US8414907B2 (en) 2005-04-28 2013-04-09 Warsaw Orthopedic, Inc. Coatings on medical implants to guide soft tissue healing
JP2009545417A (ja) * 2006-08-04 2009-12-24 ノースゲート テクノロジーズ インコーポレイテッド 体内へアクセスするための留置ポート
US8020726B1 (en) * 2006-10-18 2011-09-20 Sandia Corporation Powder dispersion system
US20080241270A1 (en) * 2007-03-30 2008-10-02 Neal Robert A Fluid composition for inhibiting surgical adhesion formation and related method of production
US9572595B1 (en) 2014-03-05 2017-02-21 Northgate Technologies Inc. In-dwelling port for access into a body
GB201511058D0 (en) * 2015-06-23 2015-08-05 Lamellar Biomedical Ltd Compositions and methods for using lamellar bodies for therapeutic purposes

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS58164513A (ja) * 1982-03-25 1983-09-29 Teijin Ltd 肺表面活性物質及びその調製法
DE3229179C2 (de) * 1982-08-05 1986-04-17 A. Nattermann & Cie GmbH, 5000 Köln Lungensurfactant
GB8613811D0 (en) * 1986-06-06 1986-07-09 Phares Pharm Res Nv Composition & method
IN166447B (de) * 1985-11-27 1990-05-12 Ethicon Inc
WO1991012026A1 (en) * 1990-02-14 1991-08-22 Macnaught Pty Limited Means of reducing surgical adhesions
WO1991017766A1 (en) 1990-05-18 1991-11-28 Tokyo Tanabe Company Limited Remedy for asthma
US5438044A (en) * 1992-06-30 1995-08-01 Rhone-Poulenc Rorer Phospholipid composition
AU7685798A (en) 1997-05-29 1998-12-30 Applied Biotechnologies Inc. Compositions and methods for preventing adhesion
GB9807298D0 (en) 1998-04-03 1998-06-03 Britannia Pharmaceuticals Ltd Medicament

Also Published As

Publication number Publication date
CA2327693A1 (en) 1999-10-14
US6719960B1 (en) 2004-04-13
ES2214748T3 (es) 2004-09-16
GB2335853A (en) 1999-10-06
GB9825971D0 (en) 1999-01-20
EP1069902A1 (de) 2001-01-24
WO1999051244A1 (en) 1999-10-14
JP2002510638A (ja) 2002-04-09
GB9807298D0 (en) 1998-06-03
CA2327693C (en) 2006-11-21
ATE259234T1 (de) 2004-02-15
JP4287050B2 (ja) 2009-07-01
EP1069902B1 (de) 2004-02-11
AU1251799A (en) 1999-10-25
DE69821655T2 (de) 2004-12-23
PT1069902E (pt) 2004-06-30
DK1069902T3 (da) 2004-06-07

Similar Documents

Publication Publication Date Title
ATE259234T1 (de) Verwendung von phospholipiden zur herstellung eines arzneimittels zur vorbeugung von adhäsionen
JP2003514835A (ja) 瘢痕を治療する方法と組成物
BR9911071A (pt) Preparações para aplicação de agentes antiinflamatórios, especialmente anti-sépticos e/ou agentes promotores da cura de feridas no trato respiratório superior e/ou no ouvido
BRPI9908182B8 (pt) composições de proteína de matriz para cura de feridas
DE69231421T2 (de) Fibrin oder fibrinogen sowie biologisch abbaubare und biokompatible polymere enthaltende zusammensetzung zur gewebebehandlung
WO1999032135A8 (en) Keratinocyte growth factor-2 formulations
ATE311849T1 (de) Verwendung von kosmetische und pharmazeutische zubereitungen enthaltend 2-decarboxy-2-phosphino prostaglandinderivate
DE60143889D1 (de) Parasiticide formulierung und methode zur herstellung dieser formulierung
ATE213164T1 (de) Verwendung von nona- und dekapeptiden zur herstellung eines arzneimittels zur bekämpfung von aids
ATE309782T1 (de) Zusammensetzung zur narbenbehandlung enthaltend eine silikonmischung
NO20000446D0 (no) Anvendelse av fysiologisk akseptable vanadiumforbindelser, salter og komplekser
MX9708803A (es) Compuestos biaromaticos de propinilo o dienilo.
HUP0000873A2 (hu) A levobupivakain arcsebészeti alkalmazása
DE69910202D1 (de) EGR-1 zur Herstellung eines Medikamentes zur Behandlung von Wunden
ATE464878T1 (de) Pharmazeutische zusammensetzung zur nasalen anwendung von fentanyl
DE69426530D1 (de) Pharmazeutische zusammensetzung zur förderung der gewebeheilung und -regenerierung und darreichungssatz
BR9809351A (pt) Tecido de bainha dérmica na cura de lesões
CA2280985A1 (fr) Composition contenant de l'uree et ses utilisations dans le domaine cosmetique et/ou dermatologique
HUP9902135A2 (hu) (+)-alfa-(2,3-Dimetoxi-fenil)-1-[2-(4-fluor-fenil)-etil]-4-piperidin-metanol alkalmazása depresszív és bipoláris rendellenességek kezelésére alkalmas gyógyszerkészítmény előállítására
BR9815708B1 (pt) composição tópica para tratar lesões cutáneas.
WO1999050239A3 (fr) Nouveaux composes heteroethynylenes et compositions pharmaceutiques et cosmetiques les contenant
YU13599A (sh) Primena farmaceutske kompozicije za dobijanje leka u obliku gela
SE9403905D0 (sv) New formulations
AU2002333536A1 (en) Carboxylate-gated-nitroxide (cgn) compounds and compositions and methods of use thereof
WO2006090824A1 (ja) ゲル組成物及びその製造方法

Legal Events

Date Code Title Description
8364 No opposition during term of opposition